[{"id":"69debedd-b9d8-4fe6-ae00-f26dd3031ab8","acronym":"","url":"https://clinicaltrials.gov/study/NCT04092348","created_at":"2021-01-18T20:01:37.466Z","updated_at":"2024-07-02T16:35:56.254Z","phase":"","brief_title":"FoxO3a and PU.1 in Acute Lymphoblastic Leukemia","source_id_and_acronym":"NCT04092348","lead_sponsor":"Assiut University","biomarkers":" FOXO3","pipe":"","alterations":" ","tags":["FOXO3"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 53","initiation":"Initiation: 08/01/2023","start_date":" 08/01/2023","primary_txt":" Primary completion: 03/30/2024","primary_completion_date":" 03/30/2024","study_txt":" Completion: 12/30/2024","study_completion_date":" 12/30/2024","last_update_posted":"2023-02-07"},{"id":"b1d76806-e319-4f41-99b1-2eaf6dccd326","acronym":"IMOX","url":"https://clinicaltrials.gov/study/NCT03473327","created_at":"2021-01-18T17:06:57.634Z","updated_at":"2024-07-02T16:37:12.882Z","phase":"","brief_title":"Immunological and Oxidative Stress Response in Relation to Abdominal Cancer Surgery","source_id_and_acronym":"NCT03473327 - IMOX","lead_sponsor":"Zealand University Hospital","biomarkers":" TP53 • IL6 • TNFA • IL2 • IL10 • TGFB1 • FOXO3 • IL1B • ISG20","pipe":" | ","alterations":" ATM expression","tags":["TP53 • IL6 • TNFA • IL2 • IL10 • TGFB1 • FOXO3 • IL1B • ISG20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ATM expression"],"overall_status":"Completed","enrollment":" Enrollment 37","initiation":"Initiation: 01/01/2016","start_date":" 01/01/2016","primary_txt":" Primary completion: 12/01/2017","primary_completion_date":" 12/01/2017","study_txt":" Completion: 12/01/2017","study_completion_date":" 12/01/2017","last_update_posted":"2018-03-22"},{"id":"94c3e75e-def5-4f6a-8473-8ed289dcaf65","acronym":"","url":"https://clinicaltrials.gov/study/NCT01339442","created_at":"2021-01-18T05:27:53.425Z","updated_at":"2024-07-02T16:37:26.259Z","phase":"Phase 1","brief_title":"BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer","source_id_and_acronym":"NCT01339442","lead_sponsor":"Washington University School of Medicine","biomarkers":" ER • PIK3CA • CCND1 • CASP3 • FOXO3","pipe":" | ","alterations":" PIK3CA mutation","tags":["ER • PIK3CA • CCND1 • CASP3 • FOXO3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PIK3CA mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e fulvestrant • buparlisib (AN2025)"],"overall_status":"Completed","enrollment":" Enrollment 31","initiation":"Initiation: 11/14/2011","start_date":" 11/14/2011","primary_txt":" Primary completion: 12/21/2016","primary_completion_date":" 12/21/2016","study_txt":" Completion: 12/28/2016","study_completion_date":" 12/28/2016","last_update_posted":"2017-01-25"}]